Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050635
Status:
COMPLETED
Last Update Posted:
2009-11-19
First Post:
2002-12-17
Brief Title:
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Currently there is an ongoing clinical trial for patients with chemotherapy induced diarrhea This trial is being conducted to evaluate the efficacy of two dose levels 30 mg and 40 mg of an investigational drug in reducing the occurrence of severe Grade 3 or 4 diarrhea during chemotherapy Eligible patients must either have experienced NCI Common Toxicity Grade 1 - 4 chemotherapy-induced diarrhea during previous chemotherapy treatment or be experiencing Grade 1-4 chemotherapy-induced diarrhea currently
In order to participate in this clinical trial patients must be male or female 18 years of age or older Inclusion into this investigational drug trial is based on the protocol entry criteria and a detailed evaluation from a participating trial investigator
In order to participate in this clinical trial patients must be male or female 18 years of age or older Inclusion into this investigational drug trial is based on the protocol entry criteria and a detailed evaluation from a participating trial investigator
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| STOP Trial | None | None | None |